LAC Med Berhad (KLSE:LACMED)
0.800
-0.040 (-4.76%)
At close: Mar 9, 2026
LAC Med Berhad Balance Sheet
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 64.89 | 15.84 | 30.45 | 23.83 |
| Short-Term Investments | 22.33 | 27.74 | 2.94 | 0.95 |
| Cash & Short-Term Investments | 87.22 | 43.58 | 33.39 | 24.77 |
| Cash Growth | 100.12% | 30.51% | 34.80% | - |
| Accounts Receivable | 80.13 | 38.74 | 68.73 | 50.96 |
| Other Receivables | 26.37 | 0.42 | 0.38 | 0.29 |
| Receivables | 106.5 | 39.16 | 69.11 | 51.24 |
| Inventory | 27.78 | 20.8 | 21.61 | 10.84 |
| Prepaid Expenses | - | 0.42 | 0.13 | 0.08 |
| Other Current Assets | - | 20.02 | 11.88 | 14.08 |
| Total Current Assets | 221.5 | 123.99 | 136.12 | 101.02 |
| Property, Plant & Equipment | 9.78 | 1.46 | 1.36 | 0.6 |
| Other Intangible Assets | 2.83 | - | - | - |
| Long-Term Deferred Tax Assets | 2.13 | 2.66 | 2.13 | 1.63 |
| Total Assets | 236.24 | 128.11 | 139.61 | 103.25 |
| Accounts Payable | 64.37 | 28.75 | 37.53 | 19.28 |
| Accrued Expenses | - | 3.62 | 4.16 | 1.42 |
| Short-Term Debt | 25.93 | 18.15 | 22.43 | 31.25 |
| Current Portion of Long-Term Debt | 0.17 | 0.77 | 0.82 | 0.77 |
| Current Portion of Leases | 0.17 | 0.11 | 0.15 | 0.12 |
| Current Income Taxes Payable | 2.91 | 2.1 | 1.84 | 1.99 |
| Current Unearned Revenue | 7.47 | 13.96 | 16.36 | 12.22 |
| Other Current Liabilities | 15.18 | 11.36 | 14.2 | 7.98 |
| Total Current Liabilities | 116.2 | 78.81 | 97.47 | 75.02 |
| Long-Term Debt | 1.07 | 1.3 | 2.06 | 2.88 |
| Long-Term Leases | 0.11 | 0.1 | 0.21 | 0.23 |
| Total Liabilities | 117.38 | 80.21 | 99.75 | 78.13 |
| Common Stock | 102.2 | 2 | 2 | 2 |
| Retained Earnings | 62.7 | 45.77 | 37.87 | 23.12 |
| Comprehensive Income & Other | -46.1 | -0 | - | - |
| Total Common Equity | 118.8 | 47.76 | 39.87 | 25.12 |
| Minority Interest | 0.06 | 0.14 | - | - |
| Shareholders' Equity | 118.86 | 47.9 | 39.87 | 25.12 |
| Total Liabilities & Equity | 236.24 | 128.11 | 139.61 | 103.25 |
| Total Debt | 27.45 | 20.42 | 25.67 | 35.24 |
| Net Cash (Debt) | 59.77 | 23.16 | 7.72 | -10.47 |
| Net Cash Growth | 158.05% | 199.90% | - | - |
| Net Cash Per Share | 0.15 | 11.58 | 3.86 | -5.23 |
| Filing Date Shares Outstanding | 622.59 | 2 | 2 | 2 |
| Total Common Shares Outstanding | 622.59 | 2 | 2 | 2 |
| Working Capital | 105.3 | 45.17 | 38.65 | 26 |
| Book Value Per Share | 0.19 | 23.88 | 19.93 | 12.56 |
| Tangible Book Value | 115.97 | 47.76 | 39.87 | 25.12 |
| Tangible Book Value Per Share | 0.19 | 23.88 | 19.93 | 12.56 |
| Machinery | - | 2.05 | 1.67 | 1.17 |
| Order Backlog | - | 55 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.